Nafamostat mesilate demonstrated a lower bleeding risk and longer filter life compared to conventional anticoagulants during blood purification.
Does nafamostat mesilate reduce bleeding risk and improve filter life in adult patients undergoing blood purification compared to conventional anticoagulants or no anticoagulation?
Nafamostat mesilate is a safe and effective anticoagulant for blood purification, offering lower bleeding risk than conventional anticoagulants and longer filter life than no anticoagulation.
Absolute Event Rate: 0% vs 0%
NM is a safe and effective anticoagulant for blood purification, showing lower bleeding risk than conventional anticoagulants and longer filter life than NA, which is particularly suitable for patients at high risk of bleeding.
Liu et al. (Wed,) reported a other. Nafamostat mesilate demonstrated a lower bleeding risk and longer filter life compared to conventional anticoagulants during blood purification.